Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1074/jbc.m702073200
Read article for free, from open access legal sources, via Unpaywall: http://www.jbc.org/article/S0021925820547911/pdf
References
Articles referenced by this article (34)
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
Annu Rev Biochem, 435-471 2001
MED: 12045103
Functions of heparan sulfate proteoglycans in cell signaling during development.
Development, (24):6009-6021 2004
MED: 15563523
Domain structure of heparan sulfates from bovine organs.
J Biol Chem, (30):17804-17810 1996
MED: 8663266
Heparan sulfate structure in mice with genetically modified heparan sulfate production.
J Biol Chem, (41):42732-42741 2004
MED: 15292174
Interactions between heparan sulfate and proteins: the concept of specificity.
J Cell Biol, (3):323-327 2006
MED: 16880267
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
J Biol Chem, (21):12960-12966 1998
MED: 9582329
Differential expression of heparan sulfate domains in rat spleen.
J Histochem Cytochem, (6):727-739 2003
MED: 12754284
Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies.
J Am Soc Nephrol, (5):1279-1288 2005
MED: 15788473
Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.
J Biol Chem, (13):10982-10986 2002
MED: 11790764
Show 10 more references (10 of 34)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.
Glycobiology, 34(8):cwae046, 01 Jun 2024
Cited by: 0 articles | PMID: 38963938 | PMCID: PMC11231949
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA.
Ann Clin Transl Neurol, 10(6):904-917, 11 May 2023
Cited by: 2 articles | PMID: 37165777 | PMCID: PMC10270249
A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells.
iScience, 24(11):103349, 29 Oct 2021
Cited by: 0 articles | PMID: 34825135 | PMCID: PMC8603209
Imaging Glycosaminoglycan Modification Patterns In Vivo.
Methods Mol Biol, 2303:539-557, 01 Jan 2022
Cited by: 1 article | PMID: 34626406
Optimal Extracellular Matrix Niches for Neurogenesis: Identifying Glycosaminoglycan Chain Composition in the Subventricular Neurogenic Zone.
Front Neuroanat, 15:764458, 04 Oct 2021
Cited by: 9 articles | PMID: 34671246 | PMCID: PMC8520954
Review Free full text in Europe PMC
Go to all (59) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.
J Biol Chem, 279(37):38346-38352, 07 Jul 2004
Cited by: 15 articles | PMID: 15247295
Novel heparan sulfate structures revealed by monoclonal antibodies.
J Biol Chem, 280(21):20516-20523, 18 Mar 2005
Cited by: 83 articles | PMID: 15778504
Differential expression of heparan sulfate domains in rat spleen.
J Histochem Cytochem, 51(6):727-739, 01 Jun 2003
Cited by: 25 articles | PMID: 12754284
The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.
Glycoconj J, 34(3):285-298, 03 Nov 2016
Cited by: 38 articles | PMID: 27812771
Review